ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 3

Acute colonic diverticulitis: Outpatient management and follow-up

Acute colonic diverticulitis: Outpatient management and follow-up
Author:
Krishnan Raghavendran, MD, FACS
Section Editor:
Martin Weiser, MD
Deputy Editor:
Wenliang Chen, MD, PhD
Literature review current through: May 2025. | This topic last updated: May 17, 2024.

INTRODUCTION — 

Diverticular disease of the colon is common. Although often diagnosed in the emergency department, patients with uncomplicated disease who are otherwise well are often treated as outpatients. Additionally, all patients will require outpatient follow-up after resolution of their acute symptoms.

The outpatient management and follow-up of acute colonic diverticulitis is the focus of this topic. Initial triage and inpatient management are discussed in another topic. (See "Acute colonic diverticulitis: Triage and inpatient management".)

The epidemiology, pathophysiology, clinical manifestations, diagnosis, complications, and surgical treatment of diverticulitis are discussed elsewhere:

(See "Colonic diverticulosis and diverticular disease: Epidemiology, risk factors, and pathogenesis".)

(See "Clinical manifestations and diagnosis of acute colonic diverticulitis in adults".)

(See "Diverticular fistulas".)

(See "Colonic diverticular bleeding".)

(See "Acute colonic diverticulitis: Surgical management".)

INITIAL OUTPATIENT CARE — 

Uncomplicated diverticulitis in patients who meet certain criteria can be managed entirely as outpatients. These criteria are outlined in this table (table 1) and discussed in detail elsewhere. (See "Acute colonic diverticulitis: Triage and inpatient management", section on 'Triage'.)

The initial care typically consists of pain control with oral analgesics (eg, acetaminophen, ibuprofen, oxycodone) and a liquid diet. Antibiotics are usually not required. Ibuprofen or other nonsteroidal anti-inflammatory drugs should be stopped as soon as the acute episode has resolved, as chronic use has been associated with diverticular complications. (See 'Dietary modification and supplements' below.)

No oral antibiotics — Antibiotics used to be the cornerstone of diverticulitis treatment. However, such practice was largely based upon retrospective studies and clinical experience rather than high-quality evidence [1,2]. In an open-label randomized trial (DINAMO) of 480 patients with imaging-confirmed uncomplicated diverticulitis whose symptoms were adequately controlled in the emergency department, outpatient treatment with or without amoxicillin-clavulanic acid resulted in similarly low rates of unscheduled return visits (6.7 versus 7 percent) or hospitalization (6 versus 3 percent) [3]. Additional trials, mostly from Europe, also showed that antibiotics may not be necessary for selected patients with uncomplicated diverticulitis who are treated in the hospital. Inpatient treatment of diverticulitis is discussed elsewhere. (See "Acute colonic diverticulitis: Triage and inpatient management", section on 'Intravenous antibiotics'.)

The exclusion criteria used in the DINAMO trial were almost identical to the criteria used to determine need for inpatient treatment (table 1). Thus, we suggest that patients with uncomplicated diverticulitis without the characteristics suggestive of either severe disease or serious comorbidities be managed initially with pain control and a liquid diet but without antibiotics [3].

Our suggestion for the selective use of antibiotics to treat uncomplicated diverticulitis is consistent with recommendations from the American Gastroenterological Association (AGA) [4,5], American Society of Colon and Rectal Surgeons (ASCRS) [6], European Association of Endoscopic Surgery (EAES)/Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) [7], and American College of Physicians (ACP) [8].

However, clinicians may reasonably choose to use antibiotics for individual patients who have major medical comorbidities, have immunocompromising conditions, use medications causing immunomodulation, or show signs of systemic disturbance. Oral antibiotics appropriate for diverticulitis are listed in this table (table 2).

Outpatient diet — There is no evidence for dietary restrictions in acute uncomplicated diverticulitis. Some guidelines allow regular diet in patients who can tolerate it, while others endorse a "modified" diet [9]. One approach is to limit patients to a liquid diet until they can be reassessed within a week, after which their diet can be liberalized to soft or regular if they demonstrate clinical improvement.

SUBSEQUENT OUTPATIENT CARE — 

Patients should be reassessed in the clinic within one week of their initial presentation to the emergency room or discharge from the hospital. Thereafter, all patients should be reassessed weekly until all symptoms resolve.

Patients who improve — Repeat imaging studies are not necessary in patients who continue to demonstrate clinical improvement. Upon resolution of all symptoms, patients should be monitored for any recurrence of symptoms. Those who had complicated diverticulitis, atypical image findings, or atypical course should undergo colonoscopy in six to eight weeks if they have not done so within the previous year. (See 'Colonoscopy for select patients' below.)

Patients who do not improve — Patients with worsening pain, new onset fever, or the inability to tolerate oral fluids should be admitted for inpatient treatment (algorithm 1). Abdominopelvic computed tomography (CT) imaging may be repeated to rule out a new complication. There is suggestion that some of these patients can be started on antibiotics as an outpatient, but no data exist to guide practice. (See "Acute colonic diverticulitis: Triage and inpatient management", section on 'Inpatient treatment'.)

In a 2019 meta-analysis of 19 retrospective studies, the readmission rate for outpatient treatment of diverticulitis is low (7 percent, 95% CI 6-9) and comparable to that of inpatient controls [10].

PERSISTENT OR RECURRENT SYMPTOMS — 

A small proportion of patients who develop acute diverticulitis do not follow the classic pattern of disease progression. Such patients have been described as having "smoldering" diverticulitis [11,12]. Patients who have chronic smoldering diverticulitis typically have subacute but protracted symptoms of left lower quadrant abdominal pain, alteration in bowel habits, and/or rectal bleeding, often after cessation of antibiotics. These symptoms are chronic and may last for longer than six months.

In a two-year longitudinal study of patients participating in the DIABOLO (DIverticulitis: AntiBiotics Or cLose Observation?) trial [13], over one-third reported persistent symptoms such as flatulence (39 percent), rumblings (31 percent), many stools (30 percent), bloating (28 percent), fullness (28 percent), and severe urgency for defecation (27 percent) [14]. However, the absolute quality-of-life scores for several of such symptoms were actually comparable to those for healthy individuals in other studies, and only 22 percent of patients with ongoing abdominal complaints experienced a recurrent episode of diverticulitis within 24 months. Thus, for patients with persistent complaints after acute diverticulitis, it is important to distinguish between true smoldering or recurrent diverticulitis and other disease entities such as irritable bowel syndrome. (See "Clinical manifestations and diagnosis of irritable bowel syndrome in adults" and "Acute colonic diverticulitis: Surgical management", section on 'Surgery for persistent symptoms'.)

Smoldering diverticulitis is characterized by the key feature of colonic inflammation, which can be demonstrated by repeat CT scan, lower endoscopy, or laboratory test (eg, fecal calprotectin) [15]. A lack of colonic inflammation suggests that the symptoms may be due to function disorders such as irritable bowel syndrome, which do not require a surgical intervention.

Patients with chronic smoldering diverticulitis should be referred for surgical evaluation [16]. Patients should be presented with the risks and benefits of colon resection so they can engage in shared decision making with the surgeon [15].

In a randomized trial of patients with either smoldering or multirecurrent diverticulitis, elective colon resection resulted in better quality-of-life scores than conservative management at one and five years [17-19]. However, surgical complications included anastomotic leak (11 percent), reoperation (15 percent), and protective stomas (19 percent).

In a systematic review, elective surgery reduced recurrence in patients with prior complicated, smoldering, or frequently recurrent diverticulitis [20].

ELECTIVE SURGERY FOR COMPLICATED DIVERTICULITIS — 

After successful nonoperative management of acute diverticulitis, elective surgery should be offered to patients who had complicated diverticulitis. There is evidence that patients with complicated diverticulitis are at higher risk of developing serious complications or dying from recurrent diverticulitis [21,22]. The 2020 American Society of Colon and Rectal Surgeons (ASCRS) guidelines recommended elective colon resection after successful nonoperative management of acute complicated diverticulitis [6].

Patients with fistulae, obstruction, and stricture obviously require definitive surgical intervention. However, the optimal management of a healed diverticular abscess is less certain [23], as some evidence suggests that it is not as significant a risk factor for future complicated recurrence [24]. Thus, for patients with a healed diverticular abscess, we suggest basing the decision to operate on the persistence of symptoms and effect on quality of life, rather than mandating surgery solely to avoid recurrent episodes. This is especially true if the patient is medically complicated. This area, however, is controversial and continues to evolve [25]. (See "Acute colonic diverticulitis: Surgical management", section on 'Patients with prior complicated attack(s)'.)

Elective colon resection is generally not offered to immunocompetent patients with a history of uncomplicated diverticulitis, regardless of the number of past episodes [4,6]. However, surgery may be an option for patients who travel extensively, and patients who live in remote areas of the country without ready access to medical care.

The management of immunocompromised patients with diverticulitis is more nuanced [26-29]. Acute diverticulitis is more severe in immunocompromised patients because their presentation is atypical and often delayed, and elective surgery carries much lower morbidity and mortality rates compared with emergency surgery [30,31]. Therefore, immunosuppression used to be considered another indication for elective colon resection. However, some immunosuppressed patients may be poor surgical candidates due to comorbid conditions; thus, the current guidelines call for a thorough surgical evaluation to determine if elective surgery is the right approach based on the severity of diverticulitis, the severity and duration of immunocompromise, and the patient's general suitability for surgery [6].

Patients can become immunocompromised from chemotherapy; immunosuppression for organ transplant; long-term glucocorticoid therapy; or chronic medical conditions such as diabetes, renal failure, or collagen-vascular disorders such as lupus [32,33]. Patients with well-controlled diabetes or human immunodeficiency virus infection can be managed similarly to the general population with diverticulitis [7]. Those with acquired immunodeficiency syndrome have higher morbidities and mortality [34]. Patients who are planning to undergo a limited course of chemotherapy should have their elective surgery delayed until after its completion.

COLONOSCOPY FOR SELECT PATIENTS — 

After the complete resolution of symptoms associated with acute diverticulitis (typically in six to eight weeks), we suggest that a colonoscopy be performed to exclude colon cancer in the following patients, unless one has been performed within the previous year:

Patients with an episode of complicated diverticulitis

Patients with atypical imaging findings for diverticulitis

Patients with an atypical course for acute diverticulitis

The cancer detection rate by colonoscopy is consistently much higher after complicated diverticulitis than after uncomplicated diverticulitis [20]. In two meta-analyses, colorectal cancer was detected by colonoscopy in 8.3 to 10.8 percent of patients with complicated diverticulitis but only in 0.5 to 0.7 percent of those with uncomplicated diverticulitis [35,36]. Thus, there is no controversy that colonoscopy should be performed after any episode of complicated diverticulitis.

The 2020 American Society of Colon and Rectal Surgeons (ASCRS) guidelines recommended colonoscopy after all complicated diverticulitis and after uncomplicated diverticulitis with imaging abnormalities or atypical courses [6]. The 2022 American College of Physicians (ACP) guidelines recommended colonoscopy after complicated diverticulitis [16].

DIETARY MODIFICATION AND SUPPLEMENTS — 

In order to prevent recurrence, patients with a history of colonic diverticulitis should consume a high-fiber diet; however, they do not need to avoid seeds, corn, and nuts [4]. Patients should also refrain from chronic or excessive use of nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin unless prescribed for cardiovascular purposes. Further studies are required before mesalamine or other agents (eg, rifaximin, probiotics) can be recommended for prevention of recurrent diverticulitis [4].

Healthy lifestyle – Patients should be advised to lead a healthy lifestyle, which entails tobacco cessation, physical activities and weight loss, and reduced meat intake [37,38]. A high-fiber diet is also recommended once the acute phase of diverticulitis has resolved [39]. This recommendation is based upon observational studies that suggested long-term fiber supplementation may reduce the incidence of recurrent diverticulitis [40,41]. Indirect support for fiber supplementation also comes from studies that demonstrated the protective effect of a high-fiber diet on the development of diverticular disease [42]. However, although a healthy lifestyle has been shown to prevent the first episode of diverticulitis, its role in secondary prevention in patients who already had diverticulitis is uncertain [43,44].

Seeds, corn, and nuts – Patients with diverticular disease have historically been advised to avoid consuming seeds, corn, and nuts out of concern that undigested fragments of such food items could become lodged within the diverticulum and incite diverticulitis. However, this theory is completely unproven. In a large prospective study of 47,228 patients, nut, corn, and popcorn consumption did not increase the risk of developing diverticulitis or its associated complications (eg, bleeding) [45]. Thus, we do not counsel patients with a history of diverticulitis against consuming seeds, corn, and nuts.

Nonsteroidal anti-inflammatory drugs and aspirin – There is observational evidence that associated both NSAIDs and aspirin with diverticular bleed and complicated diverticulitis [46-48]. Although the association does not prove causation, it is generally advised for patients with a history of diverticulitis to avoid chronic or excessive use of NSAIDs or aspirin, with the exception of those who take aspirin for cardiovascular purposes [49].

Mesalamine – Based upon the theory that chronic inflammation plays a role in diverticulitis, anti-inflammatory agents, such as mesalamine, have been used to treat diverticulitis [50-54]. A 2017 Cochrane systematic review and meta-analysis of seven randomized trials, however, found no evidence of an effect when comparing mesalamine with control for prevention of recurrent diverticulitis (31.3 versus 29.8 percent; relative risk 0.69, 95% CI 0.43-1.09; very low quality of evidence) [55]. Therefore, we do not suggest mesalamine to prevent recurrent diverticulitis [7,16,20]. There is even less evidence to support the use of other agents such as rifaximin [56] and probiotics [57].

RECURRENT DIVERTICULITIS — 

Overall, between 16 and 42 percent of patients have one or more recurrent episode(s) after nonoperative management of acute diverticulitis [21,58-60]. Thus, most patients (58 to 84 percent) do not develop recurrent diverticulitis. Two large cohort studies followed tens of thousands of patients for four years after their first episode of acute diverticulitis and documented low rates of both hospital readmission and surgery:

In an English study of over 65,000 patients managed nonoperatively for their first episode of diverticulitis, the readmission rate for recurrent diverticulitis after a minimum follow-up of four years was 11.2 percent; 0.9 and 0.75 percent required emergency and elective colectomy, respectively. Female sex, young age, smoking, obesity, and complicated initial disease were risk factors for readmission and emergency surgery by regression analyses [61].

In a Canadian study of over 14,000 patients followed for a median of almost four years, the readmission rate was 9 percent, and 1.9 and 1.7 percent required emergency and elective colectomy, respectively. In regression analyses, complicated initial disease was a risk factor for both readmission and emergency surgery, while age <50 was a risk factor for readmission but not emergency surgery [62].

Studies show that recurrent diverticulitis is usually not more severe, or "virulent," than the initial episode:

In 672 patients who were followed for five years after nonoperative management of diverticulitis, 36 percent had a recurrence at five years, but only 4 percent had a complicated recurrence (eg, abscess, perforation, or fistula) [58].

In a retrospective study of 1300 patients with acute diverticulitis, frank perforation occurred in 25 percent of patients with their first episode, 12 percent with their second episode, 6 percent with their third episode, and only 1 percent thereafter [63].

Although surgery was once advised for patients who have had two or more uncomplicated episodes of diverticulitis, there is increasing evidence that such arbitrary guidelines should be abandoned [64-66]. The guidelines from the American Society of Colon and Rectal Surgeons (ASCRS) called for an individualized approach to recommending elective sigmoid colectomy after recovery from uncomplicated diverticulitis [6]. Considering the risk of colostomies associated with elective resection, the risk of ostomy is not lower after surgery than without surgery (4 versus 1.6 percent) [67]. The complication and colostomy rates associated with surgery after four episodes were no higher than after one episode [6]. Furthermore, more episodes of diverticulitis were not associated with a higher rate of conversion from laparoscopic to open surgery [68].

Surgery, however, may be indicated in patients with recurrent diverticulitis who develop symptoms. In a systematic review of 80 studies, 20 to 35 percent of patients managed nonoperatively developed chronic abdominal pain, compared with 5 to 25 percent of patients treated surgically [69]. Overall, approximately 15 percent of patients with acute diverticulitis will require surgical intervention at some time during the course of their disease [69], nearly all of whom have had either a complicated episode or several uncomplicated episodes of diverticulitis [6].

Recurrence after surgery for uncomplicated diverticulitis occurs in 6 percent of patients at one year and 16 percent at five years [67]; patients with a colosigmoid anastomosis where the distal resection did not extend to the rectum had four times as many recurrences as those with a colorectal anastomosis [70,71]. It is therefore extremely important that the distal level of resection extend up to the rectum. (See "Acute colonic diverticulitis: Surgical management", section on 'Operative considerations'.)

SOCIETY GUIDELINE LINKS — 

Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Colonic diverticular disease" and "Society guideline links: Intra-abdominal infections in adults".)

INFORMATION FOR PATIENTS — 

UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Diverticulitis (The Basics)" and "Patient education: Diverticulitis – Discharge instructions (The Basics)")

Beyond the Basics topics (see "Patient education: Diverticular disease (Beyond the Basics)")

SUMMARY AND RECOMMENDATIONS

Initial outpatient care – Patients are initially managed with pain control with oral analgesics (eg, acetaminophen, ibuprofen, or oxycodone) and a liquid diet until they are reassessed in one week. For most patients who are appropriate candidates for outpatient management of acute uncomplicated colonic diverticulitis, we suggest against antibiotic treatment (Grade 2B). There appear to be similar outcomes regardless of antibiotic use. However, clinicians may reasonably choose to use oral antibiotics in patients who have comorbidities or systemic symptoms. When indicated, appropriate oral antibiotics are listed in this table (table 2). (See 'Initial outpatient care' above.)

Subsequent outpatient care – Patients should be reassessed clinically within a week of their initial presentation or discharge from the hospital, and weekly thereafter until the complete resolution of all symptoms. Repeat imaging studies are usually not necessary unless the patient fails to progress clinically. Patients who deteriorate or do not improve with outpatient therapy are (re)admitted for inpatient treatment (algorithm 1). (See 'Initial outpatient care' above.)

Persistent or recurrent symptoms – Patients should be reassessed after six to eight weeks of treatment. After out- or inpatient treatment of acute diverticulitis, those who have persistent or recurrent symptoms may have chronic smoldering diverticulitis, which is distinguished from other common gastrointestinal disorders (eg, irritable bowel syndrome) by the presence of colonic inflammation. Patients with chronic smoldering diverticulitis may benefit from surgical consultation for possible elective colon resection. (See 'Persistent or recurrent symptoms' above.)

Candidates for elective surgery – For most patients who have had complicated diverticulitis, we suggest elective colon resection (Grade 2C). Such patients have a greater risk of morbidity and mortality from recurrent diverticulitis and emergency surgery. Resection is not required for some asymptomatic patients with a healed diverticular abscess. (See 'Elective surgery for complicated diverticulitis' above and "Acute colonic diverticulitis: Surgical management", section on 'Patients with prior complicated attack(s)'.)

Elective colon resection is generally not offered to asymptomatic, immunocompetent patients with a history of uncomplicated diverticulitis, regardless of the number of past episodes. However, surgery may be an option for patients who travel extensively, as well as patients who live in remote areas without ready access to medical care.

Immunocompromised patients may be at increased risk for complications or death from recurrent diverticulitis, but may also be at increased risk of surgical complications. The decision for surgery is therefore individualized.

Colonoscopy and dietary modification – All patients who had complicated diverticulitis, atypical imaging findings, or atypical course, and are symptom free should undergo colonoscopy after six to eight weeks to rule out colon cancer unless one has been performed in the previous year.

After a complete recovery (typically takes six to eight weeks), patients are advised to consume a high-fiber diet and a healthy lifestyle to reduce the risk of recurrence, but not avoidance of nuts, corn, and seeds. Patients should also refrain from chronic or excessive use of nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin unless prescribed for cardiovascular purposes. (See 'Colonoscopy for select patients' above and 'Dietary modification and supplements' above.)

ACKNOWLEDGMENT — 

The editorial staff at UpToDate acknowledge Tonia Young-Fadok, MD, and John H Pemberton, MD, who contributed to earlier versions of this topic review.

  1. Schechter S, Mulvey J, Eisenstat TE. Management of uncomplicated acute diverticulitis: results of a survey. Dis Colon Rectum 1999; 42:470.
  2. Salzman H, Lillie D. Diverticular disease: diagnosis and treatment. Am Fam Physician 2005; 72:1229.
  3. Mora-López L, Ruiz-Edo N, Estrada-Ferrer O, et al. Efficacy and Safety of Nonantibiotic Outpatient Treatment in Mild Acute Diverticulitis (DINAMO-study): A Multicentre, Randomised, Open-label, Noninferiority Trial. Ann Surg 2021; 274:e435.
  4. Stollman N, Smalley W, Hirano I, AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. Gastroenterology 2015; 149:1944.
  5. Shah SD, Cifu AS. JAMA clinical guidelines synopsis: Management of acute diverticulitis. JAMA 2017; 318:291.
  6. Hall J, Hardiman K, Lee S, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis. Dis Colon Rectum 2020; 63:728.
  7. Francis NK, Sylla P, Abou-Khalil M, et al. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc 2019; 33:2726.
  8. Qaseem A, Etxeandia-Ikobaltzeta I, Lin JS, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med 2022; 175:399.
  9. Vennix S, Morton DG, Hahnloser D, et al. Systematic review of evidence and consensus on diverticulitis: an analysis of national and international guidelines. Colorectal Dis 2014; 16:866.
  10. van Dijk ST, Bos K, de Boer MGJ, et al. A systematic review and meta-analysis of outpatient treatment for acute diverticulitis. Int J Colorectal Dis 2018; 33:505.
  11. Horgan AF, McConnell EJ, Wolff BG, et al. Atypical diverticular disease: surgical results. Dis Colon Rectum 2001; 44:1315.
  12. Boostrom SY, Wolff BG, Cima RR, et al. Uncomplicated diverticulitis, more complicated than we thought. J Gastrointest Surg 2012; 16:1744.
  13. Daniels L, Ünlü Ç, de Korte N, et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg 2017; 104:52.
  14. van Dijk ST, Daniels L, de Korte N, et al. Quality of Life and Persistent Symptoms After Uncomplicated Acute Diverticulitis. Dis Colon Rectum 2019; 62:608.
  15. Morris AM, Fider JL, Mau B, Strate LL. Recurrent Lower Abdominal Pain, Altered Bowel Habits, and Malaise: Conservative or Surgical Approach to a Common Disorder. Gastroenterology 2023; 164:541.
  16. Qaseem A, Etxeandia-Ikobaltzeta I, Lin JS, et al. Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med 2022; 175:416.
  17. van de Wall BJM, Stam MAW, Draaisma WA, et al. Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol 2017; 2:13.
  18. Bolkenstein HE, de Wit GA, Consten ECJ, et al. Cost-effectiveness analysis of a multicentre randomized clinical trial comparing surgery with conservative management for recurrent and ongoing diverticulitis (DIRECT trial). Br J Surg 2019; 106:448.
  19. Bolkenstein HE, Consten ECJ, van der Palen J, et al. Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis: 5-year Follow-up Results of a Multicenter Randomized Controlled Trial (DIRECT-Trial). Ann Surg 2019; 269:612.
  20. Balk EM, Adam GP, Cao W, et al. Evaluation and Management After Acute Left-Sided Colonic Diverticulitis : A Systematic Review. Ann Intern Med 2022; 175:388.
  21. Rose J, Parina RP, Faiz O, et al. Long-term Outcomes After Initial Presentation of Diverticulitis. Ann Surg 2015; 262:1046.
  22. Devaraj B, Liu W, Tatum J, et al. Medically Treated Diverticular Abscess Associated With High Risk of Recurrence and Disease Complications. Dis Colon Rectum 2016; 59:208.
  23. Young-Fadok TM. Diverticulitis. N Engl J Med 2018; 379:1635.
  24. Aquina CT, Becerra AZ, Xu Z, et al. Population-based study of outcomes following an initial acute diverticular abscess. Br J Surg 2019; 106:467.
  25. Bendl RF, Bergamaschi R. Do Patients Mandate Resection After a First Episode of Acute Diverticulitis of the Colon with a Complication? Adv Surg 2017; 51:179.
  26. Regenbogen SE, Hardiman KM, Hendren S, Morris AM. Surgery for diverticulitis in the 21st century: a systematic review. JAMA Surg 2014; 149:292.
  27. Biondo S, Trenti L, Elvira J, et al. Outcomes of colonic diverticulitis according to the reason of immunosuppression. Am J Surg 2016; 212:384.
  28. Brandl A, Kratzer T, Kafka-Ritsch R, et al. Diverticulitis in immunosuppressed patients: A fatal outcome requiring a new approach? Can J Surg 2016; 59:254.
  29. He S, Lu P, Etzioni D, et al. Management of Acute Diverticulitis in Immunocompromised Patients-The Mayo Clinic Experience. Dis Colon Rectum 2023; 66:434.
  30. Al-Khamis A, Abou Khalil J, Demian M, et al. Sigmoid Colectomy for Acute Diverticulitis in Immunosuppressed vs Immunocompetent Patients: Outcomes From the ACS-NSQIP Database. Dis Colon Rectum 2016; 59:101.
  31. McKechnie T, Lee Y, Kruse C, et al. Operative management of colonic diverticular disease in the setting of immunosuppression: A systematic review and meta-analysis. Am J Surg 2021; 221:72.
  32. Mpofu S, Mpofu CM, Hutchinson D, et al. Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions. Ann Rheum Dis 2004; 63:588.
  33. Young-Fadok T, Sgambati S, Wolff B. Increased morbidity and mortality after colectomy in patients with lupus: A case-matched series (abstract). Dis Colon Rectum 2000; 43:A57.
  34. Gahagan JV, Halabi WJ, Nguyen VQ, et al. Colorectal Surgery in Patients with HIV and AIDS: Trends and Outcomes over a 10-Year Period in the USA. J Gastrointest Surg 2016; 20:1239.
  35. Rottier SJ, van Dijk ST, van Geloven AAW, et al. Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis. Br J Surg 2019; 106:988.
  36. Sharma PV, Eglinton T, Hider P, Frizelle F. Systematic review and meta-analysis of the role of routine colonic evaluation after radiologically confirmed acute diverticulitis. Ann Surg 2014; 259:263.
  37. Strate LL, Keeley BR, Cao Y, et al. Western Dietary Pattern Increases, and Prudent Dietary Pattern Decreases, Risk of Incident Diverticulitis in a Prospective Cohort Study. Gastroenterology 2017; 152:1023.
  38. Liu PH, Cao Y, Keeley BR, et al. Adherence to a Healthy Lifestyle is Associated With a Lower Risk of Diverticulitis among Men. Am J Gastroenterol 2017; 112:1868.
  39. Aune D, Sen A, Norat T, Riboli E. Dietary fibre intake and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr 2020; 59:421.
  40. Maconi G, Barbara G, Bosetti C, et al. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum 2011; 54:1326.
  41. Ünlü C, Daniels L, Vrouenraets BC, Boermeester MA. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Colorectal Dis 2012; 27:419.
  42. Aldoori WH, Giovannucci EL, Rockett HR, et al. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 1998; 128:714.
  43. Aune D, Sen A, Leitzmann MF, et al. Tobacco smoking and the risk of diverticular disease - a systematic review and meta-analysis of prospective studies. Colorectal Dis 2017; 19:621.
  44. Aune D, Sen A, Leitzmann MF, et al. Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr 2017; 56:2423.
  45. Strate LL, Liu YL, Syngal S, et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008; 300:907.
  46. Strate LL, Liu YL, Huang ES, et al. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology 2011; 140:1427.
  47. Aldoori WH, Giovannucci EL, Rimm EB, et al. Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men. Arch Fam Med 1998; 7:255.
  48. Longo S, Altobelli E, Castellini C, et al. Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case-control and cohort studies. Int J Colorectal Dis 2022; 37:521.
  49. Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology 2021; 160:906.
  50. Stollman N, Magowan S, Shanahan F, et al. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol 2013; 47:621.
  51. Raskin JB, Kamm MA, Jamal MM, et al. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials. Gastroenterology 2014; 147:793.
  52. Parente F, Bargiggia S, Prada A, et al. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis 2013; 28:1423.
  53. Kruis W, Kardalinos V, Eisenbach T, et al. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence. Aliment Pharmacol Ther 2017; 46:282.
  54. Kruis W, Meier E, Schumacher M, et al. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study. Aliment Pharmacol Ther 2013; 37:680.
  55. Carter F, Alsayb M, Marshall JK, Yuan Y. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis. Cochrane Database Syst Rev 2017; 10:CD009839.
  56. Festa V, Spila Alegiani S, Chiesara F, et al. Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci 2017; 21:1397.
  57. Dughera L, Serra AM, Battaglia E, et al. Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 2004; 50:149.
  58. Hall JF, Roberts PL, Ricciardi R, et al. Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum 2011; 54:283.
  59. Binda GA, Arezzo A, Serventi A, et al. Multicentre observational study of the natural history of left-sided acute diverticulitis. Br J Surg 2012; 99:276.
  60. Mäkelä JT, Kiviniemi HO, Laitinen ST. Spectrum of disease and outcome among patients with acute diverticulitis. Dig Surg 2010; 27:190.
  61. El-Sayed C, Radley S, Mytton J, et al. Risk of Recurrent Disease and Surgery Following an Admission for Acute Diverticulitis. Dis Colon Rectum 2018; 61:382.
  62. Li D, de Mestral C, Baxter NN, et al. Risk of readmission and emergency surgery following nonoperative management of colonic diverticulitis: a population-based analysis. Ann Surg 2014; 260:423.
  63. Ritz JP, Lehmann KS, Frericks B, et al. Outcome of patients with acute sigmoid diverticulitis: multivariate analysis of risk factors for free perforation. Surgery 2011; 149:606.
  64. Janes S, Meagher A, Frizelle FA. Elective surgery after acute diverticulitis. Br J Surg 2005; 92:133.
  65. Chapman JR, Dozois EJ, Wolff BG, et al. Diverticulitis: a progressive disease? Do multiple recurrences predict less favorable outcomes? Ann Surg 2006; 243:876.
  66. Klarenbeek BR, Samuels M, van der Wal MA, et al. Indications for elective sigmoid resection in diverticular disease. Ann Surg 2010; 251:670.
  67. Thornblade LW, Simianu VV, Davidson GH, Flum DR. Elective Surgery for Diverticulitis and the Risk of Recurrence and Ostomy. Ann Surg 2021; 273:1157.
  68. Colorectal Writing Group for the SCOAP-CERTAIN Collaborative. The impact of delaying elective resection of diverticulitis on laparoscopic conversion rate. Am J Surg 2015; 209:913.
  69. Morris AM, Regenbogen SE, Hardiman KM, Hendren S. Sigmoid diverticulitis: a systematic review. JAMA 2014; 311:287.
  70. Thaler K, Baig MK, Berho M, et al. Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum 2003; 46:385.
  71. Choi KK, Martinolich J, Canete JJ, et al. Elective Laparoscopic Sigmoid Colectomy for Diverticulitis-an Updated Look at Recurrence After Surgery. J Gastrointest Surg 2020; 24:388.
Topic 143861 Version 4.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟